Skip to main content

Highlights

  1. 1
    AJNR. American journal of neuroradiology · 2026
    PMID: 42055956DOISenior author

Publications

19 publications

Active

3 grants
  • Co-I
    Gene Therapy for APOE4 Homozygous Alzheimer's Disease
    National Institute on Aging · 2026–2028
    UG3AG098024-01
  • Co-I
    Brain Estrogen Imaging and Neuroendocrine Risk Identification: The Gateway to Alzheimer's Prevention in Women
    Wellcome Leap, Inc. · 2026–2027
    WELL 252161-01
  • Co-I
    Brain Estrogen Imaging and Neuroendocrine Risk Identification: The Gateway to Alzheimer's Prevention in Women
    Wellcome Leap, Inc. · 2025–2026
    WELL 252161-01
Completed grants (1)

Clinical research

4 studies

Active

4 studies
  • PI
    A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)
    PHASE3 · F. Hoffman La-Roche Ltd · OPEN TO ACCRUAL (as of 2026)
    Alzheimers Disease
    NCT07169578
  • PI
    Master screening study to determine potential trial eligibility for patients with alzheimer's disease as assessed by their biomarker status and cognition
    F. Hoffman La-Roche Ltd · OPEN TO ACCRUAL (as of 2025)
  • PI
    Clinical and Translational Cognitive Neurology Data Repository
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    Alzheimer's National Registry for Treatment and Diagnostics
    Alzheimer's Association National Office · OPEN TO ACCRUAL (as of 2024)
    Alzheimer Disease
    NCT06170268